nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—KRT5—malignant mesothelioma	0.466	0.718	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—NF2—malignant mesothelioma	0.183	0.282	CbGpPWpGaD
Dolutegravir—POU2F2—decidua—malignant mesothelioma	0.152	0.433	CbGeAlD
Dolutegravir—POU2F2—lung—malignant mesothelioma	0.103	0.292	CbGeAlD
Dolutegravir—POU2F2—testis—malignant mesothelioma	0.0967	0.275	CbGeAlD
